Training workshop on Pharmaceutical Quality, Good Manufacturing Practice & Bioequivalence, Kiev 3.-7.10.2005 Regulation documentation requirements Saila.
Session 2 part 3
Goal:. design 11C-FLB457 perospirone Why? In the Arakawa paper, where does the baseline (aka ‘control’) data come from? From Vernaleken et al…
CLINICAL STUDY AND BASIC CONCEPT GOOD CLINICAL PRACTICE
